ADRA2B 抗体
Quick Overview for ADRA2B 抗体 (ABIN5699177)
抗原
See all ADRA2B 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            免疫原
- adrenergic, alpha-2B-, receptor
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB :1:200-1:1000,IHC:1:50-1:500
- 
                                            说明
- 
                        mouse brain tissue were subjected to SDS PAGE followed by western blot with FNab00179(ADRA2B-Specific antibody) at dilution of 1:100 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            注意事项
- Avoid repeated freeze / thaw cycles.
- 
                                            储存条件
- -20 °C
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
- 
                                            别名
- ADRA2B
- 
                                            背景
- ADRA2B, also named as ADRA2L1 and ADRA2RL1, belongs to the G-protein coupled receptor 1 family. ADRA2B mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The antibody is specific to ADRA2B.
- 
                                            分子量
- 50kDa
- 
                                            UniProt
- P18089
- 
                                            途径
- EGFR Signaling Pathway, cAMP Metabolic Process
 抗原
- 
                    
 
                                     
                                     
                                    